These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29187235)

  • 1. Urine cell-free microRNA as biomarkers for transitional cell carcinoma.
    Geva GA; Gielchinsky I; Aviv N; Max KEA; Gofrit ON; Gur-Wahnon D; Ben-Dov IZ
    BMC Res Notes; 2017 Nov; 10(1):641. PubMed ID: 29187235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma.
    Matsuzaki K; Fujita K; Jingushi K; Kawashima A; Ujike T; Nagahara A; Ueda Y; Tanigawa G; Yoshioka I; Ueda K; Hanayama R; Uemura M; Miyagawa Y; Tsujikawa K; Nonomura N
    Oncotarget; 2017 Apr; 8(15):24668-24678. PubMed ID: 28160564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples.
    Kent MS; Zwingenberger A; Westropp JL; Barrett LE; Durbin-Johnson BP; Ghosh P; Vinall RL
    BMC Vet Res; 2017 Nov; 13(1):339. PubMed ID: 29141625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma.
    Heilmann RM; McNiel EA; Grützner N; Lanerie DJ; Suchodolski JS; Steiner JM
    BMC Vet Res; 2017 Apr; 13(1):112. PubMed ID: 28431528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report.
    Lodde M; Mian C; Wiener H; Haitel A; Pycha A; Marberger M
    Urology; 2001 Sep; 58(3):362-6. PubMed ID: 11549481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of the BRAF variant V595E in urine samples, smears and biopsies from canine transitional cell carcinoma].
    Aupperle-Lellbach H; Grassinger J; Hohloch C; Kehl A; Pantke P
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2018 Oct; 46(5):289-295. PubMed ID: 30541168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
    Mlcochova H; Hezova R; Stanik M; Slaby O
    Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive diagnosis of urothelial cancer in urine using DNA hypermethylation signatures-Gender matters.
    Köhler CU; Bonberg N; Ahrens M; Behrens T; Hovanec J; Eisenacher M; Noldus J; Deix T; Braun K; Gohlke H; Walter M; Tannapfel A; Tam Y; Sommerer F; Marcus K; Jöckel KH; Erbel R; Cantor CR; Käfferlein HU; Brüning T
    Int J Cancer; 2019 Nov; 145(10):2861-2872. PubMed ID: 31008534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary beta-glucuronidase activity as an initial screening test for urinary tract malignancy in high risk patients. Comparison with conventional urine cytologic evaluation.
    Ho KJ; Kuo SH
    Cancer; 1995 Aug; 76(3):473-8. PubMed ID: 8625129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real time reverse transcriptase polymerase chain reaction of urinary cytokeratin 20 detects transitional cell carcinoma cells.
    Inoue T; Nakanishi H; Inada K; Hioki T; Tatematsu M; Sugimura Y
    J Urol; 2001 Dec; 166(6):2134-41. PubMed ID: 11696722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The occult urothelial cancer.
    Ragonese M; Racioppi M; D'Agostino D; Di Gianfrancesco L; Lenci N; Bientinesi R; Palermo G; Sacco E; Pinto F; Bassi PF
    Urologia; 2016 May; 83(2):55-60. PubMed ID: 26481721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of urinary basic fibroblast growth factor excretion in patients with urothelial carcinoma.
    Chow NH; Chang CJ; Yeh TM; Chan SH; Tzai TS; Lin JS
    Clin Sci (Lond); 1996 Feb; 90(2):127-33. PubMed ID: 8829882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of computer-assisted quantitative nuclear grading in differentiation of normal urothelial cells from low and high grade transitional cell carcinoma.
    Wojcik EM; Miller MC; O'Dowd GJ; Veltri RW
    Anal Quant Cytol Histol; 1998 Feb; 20(1):69-76. PubMed ID: 9513693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.
    Gilbert SM; Veltri RW; Sawczuk A; Shabsigh A; Knowles DR; Bright S; O'Dowd GJ; Olsson CA; Benson MC; Sawczuk IS
    Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?
    Bier S; Hennenlotter J; Esser M; Mohrhardt S; Rausch S; Schwentner C; Maas M; Deininger S; Walz S; Bedke J; Stenzl A; Todenhöfer T
    Dis Markers; 2018; 2018():5823870. PubMed ID: 29651327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of microRNAs in the urine of patients with bladder cancer.
    Wang G; Chan ES; Kwan BC; Li PK; Yip SK; Szeto CC; Ng CF
    Clin Genitourin Cancer; 2012 Jun; 10(2):106-13. PubMed ID: 22386240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary cytology of transitional-cell carcinoma].
    Piazza G; Galia A; Cosentino A; Grasso G
    Pathologica; 1995 Apr; 87(2):146-7. PubMed ID: 8532407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary NMP22 as a new marker in patients with transitional cell carcinoma].
    Muzzonigro G; Minardi D; Galosi AB; Recchioni A; De Sio G; Polito M
    Arch Ital Urol Androl; 1999 Jun; 71(3):171-7. PubMed ID: 10431409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.
    Guo RQ; Xiong GY; Yang KW; Zhang L; He SM; Gong YQ; He Q; Li XY; Wang ZC; Bao ZQ; Li XS; Zhang K; Zhou LQ
    Urol Oncol; 2018 Jul; 36(7):342.e15-342.e23. PubMed ID: 29706459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for canine transitional cell carcinoma (TCC) by SERS-based quantitative urine cytology.
    Pallaoro A; Mirsafavi RY; Culp WTN; Braun GB; Meinhart CD; Moskovits M
    Nanomedicine; 2018 Jun; 14(4):1279-1287. PubMed ID: 29597048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.